Results 131 to 140 of about 2,181,061 (267)

Atmospheric mercury monitoring data across Italy: A multi-year national dataset (2020 - 2023). [PDF]

Data Brief
Bencardino M, Tassone A, Martino M, D'Amore F, Sprovieri T, Ungaro C, Andreoli V, Esposito G, Siliprandi G, Lanzani G, Angiuli L, Nocioni A, Leonardi C, Sprovieri F, Pirrone N.   +14 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Twenty years (2000-2020) of butterfly monitoring data across the contiguous United States. [PDF]

Sci Data
Henry EH, Edwards CB, Shirey V, Pippen JS, Waetjen D, Forister ML, Larsen EA, Schultz CB, Michielini J, Brockman N, Burls KJ, Drum RG, Gatch M, Glassberg J, Hamlett NV, Hershcovich S, Le C, McGaffin S, Meilinger J, Richter L, Rochefort R, Schelz C, Shapiro AM, Sullivan K, Taron DJ, Thogmartin WE, Walker A, Westphal A, Wiedmann J, Wilcockson IU, Zaspel J, Ries L.   +31 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Natural Language Processing for Automated Extraction of Continuous Glucose Monitoring Data. [PDF]

Diabetes Care
Zheng Y, Song Y, Iturrate E, Wu B, Zweig S, Johnson SB.   +5 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Long-term biodiversity monitoring data from two hydroelectric dam projects in northeast Portugal, 2006-2023. [PDF]

Sci Data
Múrias T, Figueira R, Madeira J, Bertoluci V, Beja P.   +4 more
europepmc   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Adding arterial nitrogen pressure to single-measurement monitoring data enables diagnostic lung modeling by deep learning. [PDF]

Physiol Rep
Scott PH, Anstey CM, Morgan TJ.
europepmc   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source